CYMBALTA ALERT

YOU MAY BE ENTITLED TO COMPENSATION AND DAMAGES FOR YOUR INJURIES – WE ARE AVAILABLE TO ASSIST YOU IN YOUR RECOVERY

Lawsuits Are Being Filed Against Eli Lilly, the Makers of Cymbalta, Claiming Serious Antidepressant Withdrawal Symptoms

According to class action lawsuits filed nationwide, Cymbalta has caused serious withdrawal symptoms including severe nausea, vomiting, dizziness and vertigo, hot/cold flashes, mood swings, nightmares, brain “zaps”, paresthesia (tingling, tickling, prickling or burning sensation of the skin), shaking hands and visual disturbances.

If you or a family member have used Cymbalta and have experienced withdrawal symptoms, you may be entitled to compensation.

DON’T DELAY – CALL US 888-252-0048 OR COMPLETE AND RETURN THE CLAIM FORM
CYMBALTA ALERT

CYMBALTA ALERT

  • Our firm is vigorously pursuing this matter.
  • Our clients have received millions of dollars in medical device lawsuits.
  • No Charge or Obligation for Our Experienced Attorney Review

CONTACT US NOW! Do Not Delay As The Applicable Statute Of Limitations May Result In A Complete Bar To Your Claim Regardless Of Its Merit.

About Cymbalta

Cymbalta (duloxetine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) made by Eli Lilly and is prescribed to treat major depression and generalized anxiety disorder. It is also approved to treat diabetic nerve pain, fibromyalgia and musculoskeletal pain associated with osteoarthritis and chronic lower back pain.

Studies have shown that 50%-78% of Cymbalta users experience antidepressant withdrawal symptoms after stopping the drug. However, the label states that only 1%-2% of users experience withdrawal symptoms. The class action lawsuits claim Eli Lilly failed to warn the public that the severity of the withdrawal systems were so severe that it was given its own diagnosis: Cymbalta Discontinuation Syndrome.

In 2009, the FDA issued a report that stated the Cymbalta withdrawal symptoms can be severe and last weeks or even months. The FDA also stated the company’s sales representatives and marketing materials do not adequately warn of the withdrawal symptoms and they have not developed a safe protocol for safely stopping Cymbalta. Furthermore, a study funded and conducted by Eli Lilly states up to 41% of Cymbalta users have antidepressant withdrawal symptoms and of those, 46% were moderate and 17% were severe. But the company still states on the drug label that these withdrawal symptoms are rare and only occur in about 1% of the users.

Awards & Recognition

Gilman Law LLP and its attorneys have been recognized by the leading legal publications and are listed in:


Avvo Rating
Life Member, Multi-Million Dollar Advocates Forum
Life Member, Million Dollar Advocates Forum
Super Lawyers
Lexis Nexis
LawDragon
Association of Trial Lawyers of America
Massachusetts Association of Woman's Lawyers
American Association of Justice: Leaders Forum
American Bar Association and Member of the ABA Antitrust and Litigation Sections and Forum on Franchising and Litigation Section
Public Investors Arbitration Bar Association